Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Beyond Meat (rebranding its consumer-facing identity to "Beyond") is facing a severe secular decline in its core plant-based meat analog category. Despite a massive debt-for-equity restructuring in late 2025 that cosmetically improved the balance sheet, the underlying business remains highly unprofitable with double-digit revenue declines. The company is attempting a high-risk pivot into functional plant-based beverages (Beyond Immerse) to offset the collapse of its core burger and chicken lines, but faces intense competition, weak category demand, and a looming Nasdaq delisting deadline in August 2026.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets3 analysts · as of 18 Aug 2026
Low · most bearish analyst$0.50
Mean target$0.70
High · most bullish analyst$1.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$0.5025%

The beverage pivot fails to gain traction, and core retail and foodservice channels deteriorate further. Severe material weaknesses in inventory accounting lead to restatements, and the company fails to regain Nasdaq compliance, leading to delisting or further massive equity dilution.

Base CaseCentral scenario
$0.6560%

Core revenues continue to contract at a double-digit rate due to weak category demand and distribution losses. Gross margins remain thin, and cash burn, though reduced, continues to deplete reserves. The company is forced to execute a reverse stock split to maintain its Nasdaq listing before the August 31, 2026 deadline.

Bull CaseUpside scenario
$1.0015%

The plant-based meat category stabilizes, and the new Beyond Immerse functional beverage line achieves rapid, high-margin retail adoption. Operational cost-cutting measures continue to improve gross margins, and the company successfully regains Nasdaq compliance without a dilutive reverse split.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Significant reduction in quarterly cash consumption to $11.8 million in Q1 2026, the lowest in over two years.
  • Successful elimination of approximately $900 million in debt via the late 2025 convertible note exchange.
  • Gross margin turned positive to 3.4% in Q1 2026, up from -10.1% in the year-ago period, due to cost-cutting and operational efficiencies.
Sign in / Sign up to read more
Key Investment Risks
  • Persistent double-digit revenue decline (-15.3% YoY in Q1 2026) driven by a 19.5% drop in volume sold.
  • Looming August 31, 2026 deadline to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
  • Identified material weaknesses in internal controls over financial reporting related to inventory accounting.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. A sudden, sustained inflection in consumer demand for plant-based meat analogs.
  2. Beyond Immerse beverage line scaling rapidly to over $50 million in annual revenue within its first year.
  3. Acquisition of the company by a larger consumer packaged goods or conventional food conglomerate.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.